Plain-English translation of NCT07029269 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether patients undergoing laparoscopic (minimally invasive) surgery to remove part of the stomach for cancer can recover safely without having a small drainage tube left in the abdomen after surgery. Half of the patients will follow an enhanced recovery protocol without the drainage tube, while the other half will have the drainage tube placed as is standard practice today. Researchers want to see if leaving out the drainage tube is just as safe and helps patients recover faster.
Currently, drainage tubes are routinely placed after stomach cancer surgery to prevent fluid buildup, but they can be uncomfortable and may slow recovery. This trial exists to find out whether skipping the drainage tube—while following other best-practice recovery guidelines—is just as safe and might actually help patients feel better and go home sooner.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to one of two groups: one will have surgery without a drainage tube, and the other will have surgery with a drainage tube placed. Both groups will follow an enhanced recovery program designed to help you get back on your feet quickly—including early eating and movement. You will be monitored closely after surgery, and your recovery and quality of life will be assessed using standard questionnaires at follow-up visits over several weeks to months.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China